Advanced Wound Dressing Market Size, Share & Trends Analysis Report By Product (Foam Dressings, Hydrocolloid Dressings, Alginate Dressings, Hydrogel Dressings, Others), By Application (Chronic Wounds, Acute Wounds), By End User (Hospitals, Specialty Clinics, Home Healthcare, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Advanced Wound Dressing Market Size

The global advanced wound dressing market size is valued at USD 4.62 billion in 2023 and is predicted to reach USD 7.20 billion by 2032, representing a CAGR of 5.46% over the forecast period (2024–2032).

Items for treating acute and chronic wounds, such as lesions, burns, and post-operative injuries, are included in advanced wound care. Advanced wound care treatments such as film and foam dressings, hydrogels, alginates, and hydrocolloids keep the wound moist and accelerate healing without obstructing the process. The advanced wound care industry can help people with chronic wounds by providing them with easily accessible and reasonably priced items that they can use at their leisure. Chronic wounds are becoming more common, surgeries are becoming more common, and technological advancements are driving the market forward.

Due to developments in technology, an increase in surgical operations, and an increase in the occurrence of chronic wounds worldwide, there is a growing demand for sophisticated wound dressing. The rising prevalence of chronic diseases like diabetes, cancer, and other autoimmune diseases drives the demand for advanced wound dressing. One of the leading causes of the rise in non-communicable diseases is variables like antimicrobial resistance, adoption of unhealthy and sedentary lifestyles, alcohol consumption, and smoking.

Advanced Wound Dressing Market Growth Factors

Increase in prevalence of chronic diseases

The global increase in the incidence of chronic diseases such as diabetes, cancer, and other autoimmune diseases. Antimicrobial resistance, the adoption of unhealthy and sedentary lifestyles, alcohol consumption, and smoking are all key contributors to the prevalence of non-communicable illnesses. According to National Diabetes Statistic Report 2017, published by the Centers for Disease Control and Prevention (CDC), more than 100.0 million people in the US were living with diabetes or prediabetes conditions. Furthermore, the World Health Organization estimates that diabetes caused nearly 1.6 million deaths worldwide in 2016.

The number of procedures performed has increased due to the rising frequency of chronic illnesses. As a result, wound care solutions are utilized more frequently to avoid surgical site infections. Most surgical wounds after cancer surgery are large and deep, resulting in exudates that must be handled often—advanced wound dressings including hydrogel, alginate, and foam aid in wound management and infection prevention. As a result, increased chronic illness incidence is predicted to enhance demand for wound care products, pushing market expansion.

Rising number of accidents

The market is expected to develop due to an increase in the number of incidents such as car accidents, burns, and trauma events occurring around the world. According to the WHO (2018), over 1,000,000 individuals are severely or moderately burned in India. Furthermore, according to NCBI, the incidence of burn wounds increased in 2017 in countries such as Bulgaria, Finland, the Netherlands, China, Australia, and the United Kingdom. Furthermore, the American Association for the Surgery of Trauma estimates that 1.2 million people died in automobile accidents worldwide in 2017, with 3,242 people dying per day. Road accidents are more common in countries with moderate or low income. Thus, the rising number of casualties is expected to boost the demand for advanced wound dressing, likely leading to considerable market growth over the forecast period.

Market Restraining Factors

Stringent manufacturing policies

The US FDA classifies most wound dressing products under Class I medical devices, exempted from premarket approval. A surgical dressing covers open incision wounds; thus, these products must be free from microbial contamination and manufactured in a sterile environment. Any form of microbial contamination may hinder the wound healing process and, in extreme cases, may cause additional infection at the site. Thus, manufacturing companies may not need premarket approval, but they may be required to comply with the Good Manufacturing Practices (GMP). According to these policies, the wound dressing products must be manufactured under sterile conditions. They have to undergo an extensive quality control process before launching the product.

Market Opportunities

Increasing demand for reduced hospital stay

The growing workforce for home care services can be ascribed to the rapidly increasing demand for home healthcare services. This is projected to be a significant market driver for improved wound dressings. As per the US Bureau of Labor Statistics, the number of home healthcare and personal care aides in the United States will reach 13 million by 2020. Furthermore, as the senior population grows, home healthcare services will likely become more popular, as older individuals are more inclined to use them.

• As per the Population Reference Bureau, the proportion of people aged 65 and up in the United States will rise from 52 million in 2018 to 95 million by 2060. According to this, the geriatric population in the United States will grow from 16% of the total population in 2018 to 23% in 2060. Patients who need surgery must stay in hospitals for extended periods; as a result, most patients choose home treatment for hospital stays. Patients benefit from these services, including personal care and home-delivered meals, among other things. Hence, demand for home healthcare services is predicted to increase, leading to market growth over the forecast period.

Regional Insights

North america: dominant region with 8.5% market share

North America dominated the advanced wound dressing market in 2021 and is expected to show a considerable growth rate over the forecast period. It is estimated to reach an expected USD 6,835 million by 2030 at a CAGR of 8.5%. Increasing road accidents, sports injuries, and several key players in the region are anticipated to drive the market growth. In addition, the presence of adequate skilled professionals and highly developed healthcare infrastructure is also expected to drive market growth over the forecast period.

• In 2021, the United States had the highest share of the North American advanced wound dressing market. Well-developed healthcare infrastructure, increasing awareness about the usage of advanced wound care products, and several key market players are the primary drivers of the market. In addition, an increase in the number of orthopedic procedures due to the high prevalence of sports injuries is also anticipated to drive the market.

Europe: fastest growing region with the highest cagr

Europe advanced wound dressing market is driven by factors such as the presence of well-established healthcare infrastructure and the availability of skilled professionals. It is estimated to reach an expected USD 2,700 million by 2030 at a CAGR of 4%. Moreover, favorable reimbursement coverage has increased the adoption of surgical procedures. In addition, the increasing geriatric population and rising cases of burns and trauma are also anticipated to drive the market. Thus, Europe's advanced wound dressing market is expected to witness significant growth over the forecast period.

Over the projected period, the market for advanced wound dressing is anticipated to expand quickly in Asia Pacific. It is projected that the presence of developing nations like China, India, and Japan will accelerate regional market expansion. Additionally, the region's rising need for improved wound dressings can be linked to these nations' fast-expanding medical tourism sector.

Advanced Wound Dressing Market Segmentation Analysis

By product

In the market, foam dressings lead because of their superior absorbency and adaptability, making them suitable for various wound types, especially those with moderate to heavy fluid output. Within this category, adhesive foam dressings are especially popular. They are favored for their ease of application and strong adherence, which means they stay in place without needing extra securing methods. This not only simplifies the dressing process but also reduces patient discomfort and the risk of complications, enhancing overall wound care effectiveness.

By application

In the market, chronic wounds dominate due to their high prevalence and the need for specialized, long-term care. Among chronic wounds, diabetic foot ulcers are the leading segment. Diabetic foot ulcers are particularly prevalent due to the growing incidence of diabetes worldwide, necessitating advanced dressings to manage prolonged healing and prevent complications. These ulcers are common in immobile patients and also drive demand for advanced wound care solutions that can enhance healing and minimize infection risks.

By end user

In the market, hospitals dominate, particularly the inpatient facilities segment. Inpatient facilities see a high volume of patients with complex and severe wounds requiring advanced dressing solutions. These facilities are equipped to manage diverse wound types, including chronic and acute wounds, with specialized products that facilitate healing and infection control. The high demand for advanced dressings in hospitals is driven by the need for effective wound management in critically ill or recovering patients, where comprehensive care is essential for optimal outcomes.

Recent Developments

• October 2023 - DuPont introduced a new soft skin adhesive (SSA), DuPont Liveo MG 7-9960. These innovative adhesive feature enhanced adhesion and reduced cyclic silicone content. Designed specifically for wound care dressings and medical device attachment, it offers extended wear time and gentle removal.
• June 2023 -JeNaCell launched the Epicite Balancing Wound Dressing in the German market. This dressing is particularly effective for managing chronic wounds with low to moderate exudation, including soft tissue lesions, diabetic foot ulcers, venous leg ulcers, and arterial leg ulcers.